Unleashing virtuous cycles of sustainable development goals and well‐being
Business and Society Review · 2025-03 · 130 (S1)
DOI: 10.1111/basr.12339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Business and Society Review, online erschienen am 04.02.2024. Verfasst von Farley Simon Nobre. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 149 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
This article advances sustainability towards a new logic that favors the flourishing of Sustainable Development Goals (SDGs) and well‐being from North to South. It presents a Global Dual‐Perspective (GDP) and a Dynamic Equilibrium Framework (DEF) that inform sustainability, management, and international business with a paradoxical view of the SDGs and a strengthened analysis that outlines the role of multinational enterprises (MNEs) in addressing the SDGs within and across the North–South. This article reveals that organizations will effectively unleash virtuous cycles of SDGs and well‐being when confronting and juxtaposing environmental, health, social, economic, and law‐oriented goals. Furthermore, virtuous cycles will be more successful when splitting and integrating short‐ and long‐term conflicting goals within and across the North–South to fuel systemic resilience and sustainable development.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Nobre, F. S. (2025). Unleashing virtuous cycles of sustainable development goals and well‐being. Business and Society Review, 130(S1). https://doi.org/10.1111/basr.12339
Vancouver
Nobre FS. Unleashing virtuous cycles of sustainable development goals and well‐being. Business and Society Review. 2025;130(S1). doi:10.1111/basr.12339
BibTeX
@article{Nobre2025,
author = {Nobre, Farley Simon},
title = {Unleashing virtuous cycles of sustainable development goals and well‐being},
journal = {Business and Society Review},
year = {2025},
volume = {130},
number = {S1},
doi = {10.1111/basr.12339}
}
EUVIMED